Jae S Cho

Dr. Jae S Cho


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2020 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
AKAlexander H. King
Alexander H. King
ASAlvin H. Schmaier
Alvin H. Schmaier
KHKarem C. Harth
Karem C. Harth
NKNorman H. Kumins
Norman H. Kumins
VWVirginia L. Wong
Virginia L. Wong
JCJae S Cho
Jae S Cho

20 March 2023 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
JSJustin A. Smith
Justin A. Smith
LYLucy Yang
Lucy Yang
LCLin Chen
Lin Chen
NKNorman Kumins
Norman Kumins
JCJae S Cho
Jae S Cho
BCBenjamin Colvard
Benjamin Colvard

1 July 2020 in Journal of Vascular Surgery
Verified
Journal Article
Closed access
AKAlexander H. King
Alexander H. King
RARavi N. Ambani
Ravi N. Ambani
KHKarem C. Harth
Karem C. Harth
VKVikram S. Kashyap
Vikram S. Kashyap
NKNorman H. Kumins
Norman H. Kumins
JCJae S Cho
Jae S Cho

1 October 2021 in International Angiology
Verified
Journal Article
Closed access
AKAlexander H. King
Alexander H. King
SKStephen Kwan
Stephen Kwan
ASAlvin H. Schmaier
Alvin H. Schmaier
NKNorman H. Kumins
Norman H. Kumins
KHKarem C. Harth
Karem C. Harth
JCJae S Cho
Jae S Cho
Article: Elevated neutrophil to lymphocyte ratio is associated with decreased amputation-free survival after femoropopliteal percutaneous revascularization - International Angiology 2021 October;40(5):442-9 - Minerva Medica - Journals

1 December 2021 in Journal of Stroke and Cerebrovascular Diseases
Verified
Journal Article
Closed access
AKAlexander H. King
Alexander H. King
AKAnn H. Kim
Ann H. Kim
SKStephen Kwan
Stephen Kwan
JLJasmine Lee
Jasmine Lee
ASAlvin H. Schmaier
Alvin H. Schmaier
JCJae S Cho
Jae S Cho

1 October 2019 in International Angiology
Verified
Journal Article
Closed access
SLSungho Lim
Sungho Lim
MMMaria Mora-Pinzon
Maria Mora-Pinzon
TPTaeyoung Park
Taeyoung Park
WYWilliam Yoon
William Yoon
PCPaul R. Crisostomo
Paul R. Crisostomo
JCJae S Cho
Jae S Cho
Background: Recent advances in best medical therapy (BMT) has been associated with reduced risk of stroke similar to that observed following surgical carotid rev ascularization (CR). Thus, it remains uncertain which subset(s) of patients would benefit from prophylactic CR+BMT for asymptomatic carotid stenosis (ACS) over BMT alone. The purpose of this study was to analyze the contemporary experience in the management of >70% ACS in an academic institution, to compare the short- and long-term outcomes of BMT alone against CR+BMT, and to identify risk factors for the development of future cerebrovascular events. Methods: A retrospective e review of all patients with severe ACS between January 2005 and December 2012 at Loyola University Medical Center and its affiliated Edward Hines Jr. Veterans Administration Hospital was conducted. Baseline patient characteristics. medications, and follow-up data were collected from electronic medical records, and treatment outcomes were compared. The random forest method was performed to select potential important variables for the development of late stroke. The recursive partitioning regression analysis (RPRA) was performed to identify the patient subgroup at increased risk of future stroke. Results: Of 409 patients identified; 247 were treated with CR and 162 with BMT. Between these groups with CR+BMT and BMT alone, the mean age was 69.1 +/- 8.2 versus 75.5 +/- 9.0, respectively (P50% who are active smokers are at the highest risk for stroke after CR (20.0% in total, 4.0% per year). Conclusions: Prophylactic CR+BMT does not provide overall late stroke prevention compared with BMT alone. Diabetics with a history of stroke, in particular, are at an increased risk of stroke despite BMT. Timely CR+BMT for high-risk patients is still indicated.